ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 22.36% of RNAZ shares are held by financial institutions. RENAISSANCE TECHNOLOGIES LLC is the top corporate investor, holding 0 shares valued at -. A 0% stake in TransCode Therapeutics, Inc. is owned by the company. STATE STREET CORP owns 21.02K shares valued at $7.12K, which translates its holding of 0.01% of the stake in the company.
Among the RNAZ insiders holding of 0.01% of the stake in company, DUDLEY ROBERT MICHAEL, Chief Executive Officer, holds the largest shares of 180.26K. FITZGERALD THOMAS A, Chief Financial Officer, is the second largest RNAZ insider with ownership of 56.32K shares. , , stands third with possession of - shares of that stake.